References
- Lawson JA, Senthilselvan A. Asthma epidemiology: has the crisis passed? Curr. Opin. Pulm. Med.11(1), 79–84 (2005).
- Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol.22, 789–815 (2004).
- Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol. Rev.87(1), 69–98 (2007).
- Maisi P, Prikk K, Sepper R et al. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS110(11), 771–782 (2002).
- Hakonarson H, Bjornsdottir US, Halapi E et al. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc. Natl Acad. Sci. USA102(41), 14789–14794 (2005).
- de Torre C, Ying SX, Munson PJ et al. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics6(13), 3949–3957 (2006).
- Kiss A, Montes M, Susarla S et al. A new mechanism regulating the initiation of allergic airway inflammation. J. Allergy Clin. Immunol.120(2), 334–342 (2007).
- Wu J, Kobayashi M, Sousa EA et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol. Cell Proteomics4(9), 1251–1264 (2005).
- Ghosh S, Janocha AJ, Aronica MA et al. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J. Immunol.176(9), 5587–5597 (2006).
- Jeong H, Lee SY, Lee EJ et al. Proteomic analysis of peripheral T-lymphocytes in patients with asthma. Chest132, 489–496 (2007).
- Murphy VE, Johnson RF, Wang YC et al. The effect of maternal asthma on placental and cord blood protein profiles. J. Soc. Gynecol. Investig.12(5), 349–355 (2005).
- Marko-Varga GA, Fehniger TE. Microscale protein expression profiling during disease evolvement. J. Chromatogr. A1053(1–2), 279–290 (2004).
- Granger J, Siddiqui J, Copeland S et al. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics5(18), 4713–4718 (2005).
- Greenlee KJ, Corry DB, Engler DA et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J. Immunol.177(10), 7312–7321 (2006).
- Zheng T, Zhu Z, Wang Z et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest.106(9), 1081–1093 (2000).
- Corry DB, Rishi K, Kanellis J et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat. Immunol.3(4), 347–353 (2002).
- Corry DB, Kiss A, Song LZ et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J.18(9), 995–997 (2004).
- Webb DC, McKenzie AN, Foster PS. Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J. Biol. Chem.276(45), 41969–41976 (2001).
- Aulak KS, Koeck T, Crabb JW et al. Proteomic method for identification of tyrosine-nitrated proteins. Methods Mol. Biol.279, 151–165 (2004).
- Handy DE, Loscalzo J. Nitric oxide and posttranslational modification of the vascular proteome: S-nitrosation of reactive thiols. Arterioscler. Thromb. Vasc. Biol.26(6), 1207–1214 (2006).
- Aulak KS, Miyagi M, Yan L et al. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc. Natl Acad. Sci. USA98(21), 12056–12061 (2001).